Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6389-6395
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6389
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6389
Laboratory test | Before tofacitinib | After tofacitinib |
Albumin | 3.6 g/dL | 4.8 g/dL |
C-reactive protein | 3.9 mg/dL | 0.0 mg/dL |
White blood cell count | 11200/μL | 4500/μL |
Erythrocyte sedimentation rate | 20 mm | 10 mm |
Red blood cell count | 413 × 104/μL | 448 × 104/μL |
Hemoglobin | 12.4 g/dL | 14.3 g/dL |
Hematocrit | 36.5% | 41.7% |
Platelet count | 14.5 × 104/μL | 25.2 × 104/μL |
- Citation: Komeda Y, Sakurai T, Sakai K, Morita Y, Hashimoto A, Nagai T, Hagiwara S, Matsumura I, Nishio K, Kudo M. Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report. World J Clin Cases 2020; 8(24): 6389-6395
- URL: https://www.wjgnet.com/2307-8960/full/v8/i24/6389.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i24.6389